Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/07/2012US20120141401 Soft anticholinergic zwitterions
06/07/2012US20120141396 Skin disinfectant with quaternary ammonium polymers
06/07/2012US20120141392 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
06/07/2012US20120141391 Use of creatine or creatine compounds for skin preservation
06/07/2012US20120141384 Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
06/07/2012US20120141383 Preparation comprising a creatine component, method for the production thereof, and the use thereof
06/07/2012US20120141382 Aptamer modulators of complement protein c3 and biologically active proteolytic products thereof
06/07/2012US20120141380 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012US20120141378 Methods for treating chronic kidney disease
06/07/2012US20120141377 Compositions and methods for treating cancer
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
06/07/2012US20120138506 Methods of treatment and pharmaceutical composition
06/07/2012US20120138056 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
06/07/2012CA2834713A1 Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
06/07/2012CA2832426A1 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
06/07/2012CA2820550A1 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
06/07/2012CA2819944A1 Modified single-stranded polynucleotide
06/07/2012CA2819840A1 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
06/07/2012CA2819829A1 Compositions and methods for treating foxp3+ treg related diseases
06/07/2012CA2819822A1 Oxazolo [5,4-b] pyridin-5-yl compounds and their use for the treatment of cancer
06/07/2012CA2819734A1 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012CA2819673A1 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819671A1 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819669A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
06/07/2012CA2819666A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819648A1 Substituted purine and 7-deazapurine compounds
06/07/2012CA2819642A1 Histone inhibition
06/07/2012CA2819633A1 Pharmaceutical cream compositions and methods of use
06/07/2012CA2819628A1 Folic acid - ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions
06/07/2012CA2819625A1 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
06/07/2012CA2819624A1 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012CA2819619A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819616A1 Methods for treating diseases of the retina
06/07/2012CA2819613A1 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819609A1 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819603A1 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819598A1 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819597A1 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819594A1 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819560A1 Treatment of jak2-mediated conditions
06/07/2012CA2819518A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012CA2819508A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012CA2819501A1 Hybrid cyclic libraries and screens thereof
06/07/2012CA2819471A1 Compounds and methods for skin repair
06/07/2012CA2819468A1 Chemokine cxcr4 receptor modulators and used related thereto
06/07/2012CA2819460A1 Orally disintegrating tablet
06/07/2012CA2819457A1 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012CA2819442A1 Use of sigma ligands in bone cancer pain
06/07/2012CA2819410A1 Heterocyclic derivates, preparation processes and medical uses thereof
06/07/2012CA2819400A1 Bicyclic compound
06/07/2012CA2819399A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
06/07/2012CA2819389A1 5-methyl-1- (naphthalen-2-yl) -1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
06/07/2012CA2819333A1 Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
06/07/2012CA2819307A1 Topical compositions for preserving or restoring the integrity of mucosae
06/07/2012CA2819262A1 Increasing drug bioavailability in naltrexone therapy
06/07/2012CA2819251A1 Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
06/07/2012CA2819246A1 Liquid viral formulations
06/07/2012CA2819240A1 Aptamer bioconjugate drug delivery device
06/07/2012CA2819236A1 Lyophilized viral formulations
06/07/2012CA2819215A1 Pyrazole compounds having therapeutic effect on multiple myeloma
06/07/2012CA2819212A1 Infusion preparation
06/07/2012CA2819206A1 Use of pacap for treating viral infections in aquatic organisms
06/07/2012CA2819106A1 Kat ii inhibitors
06/07/2012CA2819102A1 Kat ii inhibitors
06/07/2012CA2819039A1 Process for the preparation of a ppi-containing pharmaceutical product
06/07/2012CA2819009A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
06/07/2012CA2819003A1 Methods for reducing binge or compulsive eating
06/07/2012CA2818984A1 Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
06/07/2012CA2818882A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
06/07/2012CA2818853A1 Compounds
06/07/2012CA2818713A1 Process for the preparation of morpholinyl anthracycline derivatives
06/07/2012CA2818650A1 Glucan compositions
06/07/2012CA2818648A1 Glucan gels
06/07/2012CA2818584A1 Glucans
06/07/2012CA2818495A1 Methods for the treatment of fibromyalgia and chronic fatigue syndrome
06/07/2012CA2818314A1 Method for the preparation of high-purity pharmaceutical intermediates
06/07/2012CA2818187A1 Bromodomain inhibitors and uses thereof
06/07/2012CA2818161A1 Novel compound and medical use thereof
06/07/2012CA2818068A1 Compound formulations
06/07/2012CA2818067A1 New treatments of hepatitis c virus infection
06/07/2012CA2817968A1 Combination of checkpoint kinase 1 inhibitors and wee 1 kinase inhibitors
06/07/2012CA2817654A1 Once daily formulation of lacosamide
06/07/2012CA2817417A1 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
06/07/2012CA2816426A1 Alaninyl maytansinol antibody conjugates
06/07/2012CA2815821A1 Monobactams
06/07/2012CA2815374A1 Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
06/06/2012EP2460881A1 Proteoglycan degrading mutants for treatment of CNS
06/06/2012EP2460810A1 Novel flavanone derivative
06/06/2012EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2460804A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
06/06/2012EP2460801A1 Bicyclic compound and use thereof for medical purposes
06/06/2012EP2460800A1 Substituted aminothiazole derivatives with anti-HCV activity
06/06/2012EP2460798A2 Apaf-1 inhibitor compounds
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2460793A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors
06/06/2012EP2460791A1 Indole derivative and pharmacologically acceptable salt thereof
06/06/2012EP2460787A1 Amide compounds and their use as PGE2 antagonists.
1 ... 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 ... 7860